M L 9 (Levothyroxine 112 mcg (0.112 mg))
Pill imprint M L 9 has been identified as Levothyroxine sodium 112 mcg (0.112 mg).
Levothyroxine is used in the treatment of hashimoto's disease; underactive thyroid; hypothyroidism, after thyroid removal; tsh suppression; myxedema coma (and more), and belongs to the drug class thyroid drugs. Studies show no risk during pregnancy. Levothyroxine 112 mcg (0.112 mg) is not a controlled substance under the Controlled Substance Act (CSA).
- M L 9
- 112 mcg (0.112 mg)
- 9.00 mm
- Prescription only
- Drug Class:
- Thyroid drugs
- Pregnancy Category:
- A - Studies show no risk
- CSA Schedule:
- Not a controlled drug
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- butylated hydroxyanisole
sodium lauryl sulfate
D&C Red No. 27
D&C Red No. 30
|NDC Code||Manufacturer / Repackager|
|43063-0230||PDRX Pharmaceuticals Inc (repackager)|
|66267-0651||Nucare Pharmaceuticals Inc (repackager)|
|54868-6097||Physicians Total Care Inc (repackager)|
Note: Inactive ingredients may vary.
More about levothyroxine
- Levothyroxine capsules
- Levothyroxine solution
- Levothyroxine (Advanced Reading)
- Levothyroxine Injection (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.